CV Mehta MD Medical Corp

Hemet, California 92543

0 studies enrolling now · 5 studies all time

What they study most

Lupus Erythematosus, Systemic, Rheumatoid Arthritis

Studies at this site

• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants — Completed
• Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) — Completed
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed